Similarly, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are widely used in patients with hypertension, heart failure, or post-myocardial infarction, and have been shown to improve cardiovascular prognosis [34,35]. This evidence concerns the gene ACE and heart failure.